Abstract Background/Aim The soluble interleukin‐2 receptor (sIL‐2R) serve as a valuable biomarker for tumors in human patients. as its levels increase during the activation of T lymphocytes in clinical states such as inflammation. infection. and tumor. https://mqtimers.shop/product-category/han/